Browse

Abrogation of hyperosmotic impairment of insulin signaling by a novel class of 1,2-dithiole-3-thiones through the inhibition of S6K1 activation

Cited 19 time in Web of Science Cited 19 time in Scopus
Authors
Bae, Eun Ju; Yang, Yoon Mee; Kim, Sang Geon
Issue Date
2008
Publisher
American Society for Pharmacology and Experimental Therapeutics (ASPET)
Citation
Mol Pharmacol 73:1502-1512
Keywords
Adaptor Proteins, Signal TransducingAdipocytes/drug effects/metabolismAnimalsCell LineEnzyme Activation/drug effectsGlucose/metabolismGlycogen Synthase Kinase 3/metabolismHumansInsulin/*metabolismInsulin Receptor Substrate ProteinsMiceMuscle Fibers, Skeletal/drug effects/metabolismMutant Proteins/metabolismOsmotic Pressure/drug effectsPhosphorylation/drug effectsPhosphoserine/metabolismPyrazines/pharmacologyRibosomal Protein S6 Kinases/antagonists & inhibitors/*metabolismSignal Transduction/*drug effectsThiones/chemistry/*pharmacologyTumor Necrosis Factor-alpha/pharmacology
Abstract
A previous study from this laboratory showed that oltipraz and synthetic dithiolethiones prevent tumor necrosis factor-alpha-induced hepatic insulin resistance via AMP-activated protein kinase-dependent p70S6 kinase (S6K) 1 inhibitory pathway. This study investigated whether oltipraz and a novel class of 1,2-dithiole-3-thiones were capable of preventing insulin resistance induced by hyperosmotic stress, thereby enhancing insulin-dependent signals, and, if so, whether the restoration of insulin signal was mediated with the inhibition of S6K1 activity stimulated by hyperosmotic stress. In HepG2 cells, oltipraz treatment inhibited insulin receptor substrate (IRS) 1 serine phosphorylation, a marker of insulin resistance, induced by sorbitol-, mannitol-, or sodium chloride-induced hyperosmotic stress. Consequently, this allowed cells to restore insulin signals, which was evidenced by decrease in the ratio of serine to tyrosine phosphorylations of IRS1 and increase in the phosphorylations of Akt and glycogen synthase kinase (GSK) 3beta. Hyperosmotic stress markedly activated S6K1; S6K1 activation was completely abolished by oltipraz pretreatment. An experiment using dominant-negative S6K1 supports the essential role of S6K1 in the hyperosmolarity-stimulated phosphorylation of IRS1. Transfection of constitutive active mutant S6K1 eliminated the protective effect of oltipraz on GSK3beta phosphorylation, indicating that oltipraz restores insulin signaling by inhibiting S6K1 activation. A variety of synthetic 1,2-dithiole-3-thione derivatives also inhibited S6K1 activity and insulin resistance induced by hyperosmotic stress in HepG2 cells. The results of this study demonstrate that a novel class of 1,2-dithiole-3-thiones improve insulin sensitivity under the condition of hyperosmotic stress, which results from the inhibition of S6K1 activation.
ISSN
1521-0111 (Electronic)
Language
English
URI
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18252807

https://hdl.handle.net/10371/21296
DOI
https://doi.org/10.1124/mol.107.044347
Files in This Item:
There are no files associated with this item.
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Program in Clinical Pharmacology (협동과정-임상약리학전공)Journal Papers (저널논문_협동과정-임상약리학전공)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse